Vabysmo

Medicinal product

(Invented) name

Vabysmo

Active substance (s)

Faricimabas

Strength

120 mg/ml

Pharmaceutical form

injekcinis tirpalas užpildytame švirkšte

Route (s) of administration

vartoti į stiklakūnį

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

S01LA09, faricimab

Marketing authorisation holder

Roche Registration GmbH, Vokietija

Date of authorisation

2022-09-15

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

1 ml injekcinio tirpalo yra:	1 ml
Faricimabas	120 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
122486	108596	1108596	užpildytas švirkštas	0,175 ml N1 (+injekcinė adata su filtru)		Receptinis	EU/1/22/1683/002	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2022-09-15	Registruotas